Data management

Trials App empowers physicians to refer patients to trials

17-May-2022 By Jenni Spinner

IllumiCare has added the app to its Smart Ribbon point-of-care information tool, enabling providers to connect patients to appropriate clinical studies.

Veeva launches Vault CTMS with Bristol Myers Squibb

17-May-2022 By Jenni Spinner

The pharmaceutical company reportedly opted to implement the cloud software provider's clinical trial management system to help streamline its processes.

Breast cancer trial patient participants younger than ever: Phesi

16-May-2022 By Jenni Spinner

The company’s analysis of 2.5m patients worldwide suggest a growing proportion of younger patients, with implications for future study design and deployment.

Elligo, Whyze Health partner to expand reach to European patients

12-May-2022 By Jenni Spinner

The two companies are forming a European Medical Advisory Committee to better connect patients and physicians, inviting other trial professionals to join in.

Collaboration, communication can benefit patient advocacy groups: IQVIA

12-May-2022 By Jenni Spinner

Leaders from the biotech company share advice on how such organizations can make the most of often limited resources via smart strategy and collaboration.

People on the Move: May 2022

05-May-2022 By Jenni Spinner

This month’s news on partnerships, appointments, expansions, and investment includes Javara, ACG, Phastar, Elligo Health Research, and other notable companies.

Next-generation data management calls for advanced tools: Saama

05-May-2022 By Jenni Spinner

A leader from the clinical technology company discusses some of the pain points in data collection and analysis, and tools that can help users level up.

Alliance works to help struggling trials transition to DCT

03-May-2022 By Jenni Spinner

ObvioHealth and 1nHealth have joined to launch an initiative aimed at helping clinical trials avoid being shut down by smoothing the change to decentralized.

AI use in life science not yet at full potential: IBM Research

03-May-2022 By Jenni Spinner

Leaders from the R&D tech company weigh in on how use of artificial intelligence has grown, ongoing challenges to effective adoption, and what lies ahead.

Vocal biomarker use can elevate patient monitoring: Sonde Health

28-Apr-2022 By Jenni Spinner

A leader from the health tech company explains how voice-based technologies could transform monitoring of patients with dementia, Alzheimer’s, and other conditions.

Advanced analytic tools can improve safety reporting: IQVIA

20-Apr-2022 By Jenni Spinner

An expert from the health tech company explains how AI, natural language processing, and other tools can improve pharmaceutical product safety reporting.

Clinical trial evolution, innovation center of Oracle Health Sciences event

20-Apr-2022 By Jenni Spinner

The two-day Oracle Health Sciences Connect will gather an array of research experts to discuss how to make the most of emerging technologies and practices.

RWE can boost trial acceleration, cost efficiency, and inclusivity

13-Apr-2022 By Jenni Spinner

An expert from trial tech specialist Komodo Health talks about how real-world evidence use could elevate study design, conserve costs, and improve recruitment.

UK-based collaborators to create world’s largest cancer database

12-Apr-2022 By Jenni Spinner

The partnership among three research and data specialists is aimed at creating a global database to support faster development of novel cancer treatments.

Former Johnson & Johnson, Bristol Myers Squibb executive to lead COTA

12-Apr-2022 By Jenni Spinner

Miruna Sasu has been named president and CEO of the company, which uses RWD and analytics in advancing oncology drug development and clinical trial diversity.

Winterlight Labs pitches in on decentralizing Alzheimer’s research

11-Apr-2022 By Jenni Spinner

The biomarker developer is partnering with Alzheimer Center Amsterdam on decentralized assessment of patient cognition and function in preclinical research.

SubjectWell expands trial recruitment marketplace to oncology indications

11-Apr-2022 By Nick Taylor

The recruitment tech specialist has added oncology clinical studies to its marketplace, providing sponsors with a larger pool of patients to choose from.

People on the Move: April 2022

11-Apr-2022 By Jenni Spinner

This month’s news includes hiring, promotions, expansions, and acquisitions at H Clinical, Charles River, DHL Supply Chain, X-Chem, and other key companies.

Future of clinical development highlighted in online event

07-Apr-2022 By Jenni Spinner

Experts from the Decentralized Trials and Research Alliance and Rafael Pharmaceuticals discuss progress and possibilities during Clinical Development Advances.

Big pharma experts join forces to drive automation of data workflow

05-Apr-2022 By Nick Taylor

Leaders from some of the industry’s most notable companies are working together to streamline and automate IDMP workflow and come up with various standards.

Digital Medicine Society launches digital endpoint toolkit

04-Apr-2022 By Jenni Spinner

Working with numerous partners, DiMe has introduced the 3Ps of Digital Endpoint Value to help inclusion of digital endpoints in drug reimbursement decisions.

Embracing clinical tech can benefit all stakeholders: IQVIA

31-Mar-2022 By Jenni Spinner

An expert from the clinical technology solutions provider discusses some of the top challenges associated with technology adoption, and how to tackle them.

Ukraine war dramatically impacting global clinical development: Phesi

24-Mar-2022 By Jenni Spinner

The company’s analysis of clinical research activity in the region shows the conflict will have long-lasting effects that reach beyond the country’s borders.

Tech Innovations: March 2022

17-Mar-2022 By Jenni Spinner

The latest news on software, manufacturing solutions, partnerships, and more includes IQVIA, TFF Pharmaceuticals, Quotient Sciences and other key companies.

Praxis: ‘No quick fix’ for increasing clinical trial inclusivity

16-Mar-2022 By Jenni Spinner

A leader from the patient recruitment specialist discusses the industry’s ongoing challenges with patient population diversity, and potential solutions.

Oracle: How can clinical trials better fill the patient inclusivity gap?

16-Mar-2022 By Jenni Spinner

While strides have been made recruiting more representative patient populations, more can and should be done, according to an Oracle Health Sciences leader.

RWD-based software aimed at reaching underrepresented patient communities

16-Mar-2022 By Jenni Spinner

Cloud-based Clarify Trials is real-world evidence-based software intended to improve recruitment of clinical study patients from underrepresented communities.

The right tech can fill gap between lab scientist and data: ACD/Labs

16-Mar-2022 By Jenni Spinner

An expert from the R&D tech provider discusses how automation, integration, and other tools can help with effective access and analysis of lab information.

Industry experts discuss clinical revolution in online event

14-Mar-2022 By Jenni Spinner

During Outsourcing-Pharma’s March 23 webinar, Clinical Development Advances, leaders from different areas will share innovative technology and practices.

Pharma leaders should step up on artificial intelligence: ConcertAI

14-Mar-2022 By Jenni Spinner

An executive from the AI specialist discusses how recent advances have provided opportunities for industry professionals to champion new ways of thinking.

App taps into patient data to explore human side of cancer

10-Mar-2022 By Jenni Spinner

Patient-centric company Belong.life has developed an app designed to inform cancer research by offering a holistic view of the lives of people with cancer.

Connecting patients to sites, info key to study success: StudyKIK

09-Mar-2022 By Jenni Spinner

A leader from the Syneos Health company explains how innovative tech can elevate patient recruitment and engagement, even with the challenges DCTs can face.

Despite rapid DCT evolution, there’s still room for progress: Curavit

09-Mar-2022 By Jenni Spinner

A leader from the VCRO shares how far the industry has come with decentralized adoption, where opportunities for improvement exist, and what lies ahead.

Making the jump to decentralized requires a thoughtful approach: PPD Clinical Research Services

09-Mar-2022 By Jenni Spinner

Changing to DCT is more than merely flipping a switch; two leaders from the Thermo Fisher Scientific business offer advice for implementing the format.

Oncology decentralized trials call for special consideration: Encapsia

09-Mar-2022 By Jenni Spinner

A leader from the eClinical solutions provider talks about the unique considerations that cancer studies have at every stage, and how technological solutions can help address them.

Medidata, Circuit Clinical partner in decentralized clinical trial push

08-Mar-2022 By Nick Taylor

Integrated research organization Circuit Clinical will standardize its decentralized operations with Medidata’s RAVE and myMedidata technological offerings.

Boehringer Ingelheim, Lifebit team up to build data platform

07-Mar-2022 By Jenni Spinner

The pharma firm has allied with the biotech to create a scalable data, analytics, and infrastructure platform to generate insights from healthcare biobanks.

Eversana, Thread connect RWD and decentralized trial platforms

07-Mar-2022 By Nick Taylor

The two companies, along with Datavant, will combine real-world data and decentralized platforms to yield better patient information management and insights.

scope 2022

Data history visibility keeps clinical studies on track: Almac

01-Mar-2022 By Jenni Spinner

Experts from the clinical tech firm talk data challenges and how monitoring technology can enable sites and sponsors to better manage audit trail reviews.

Medable, Cognizant to collaborate on decentralized trial tech

01-Mar-2022 By Nick Taylor

Medable has added Cognizant to its Medable Partner Network, designed to help companies launch their clinical trials more quickly and run them more efficiently.

rare disease day

Rare diseases, very special patients highlighted in event

28-Feb-2022 By Jenni Spinner

The recent Outsourcing-Pharma webinar hosted a trio of industry experts highlighting challenges, opportunities, and innovations in the rare disease realm.

rare disease day 2022

Specialized CRO ‘fills the gap’ for rare disease research

28-Feb-2022 By Jenni Spinner

With a specific focus on clinical trials involving treatments for rare diseases, Orphan Reach seeks to build upon the services that conventional CROs offer.

rare disease day 2022

Rare disease research center to use Trialbee recruitment tech

28-Feb-2022 By Jenni Spinner

Ergomed, a global contract research organization, is partnering with Trialbee to improve patient recruitment at its new Rare Disease Innovation Center.

Parexel, Medidata extend decentralized clinical trial partnership

21-Feb-2022 By Jenni Spinner

The two companies, which have been collaborating for 15 years, reportedly will focus on elevating decentralized trial solutions to develop new therapies.

Expect growth, innovation in digital health landscape: BCG Digital Ventures

17-Feb-2022 By Jenni Spinner

In its forward-looking report on digital health, the consulting outfit offers predictions on what changes are ahead and how they might impact the field.

Tech Innovations: February 2022

17-Feb-2022 By Jenni Spinner

This month’s list of announcements about technology, funding, and more includes Medable, Clarify Health, Thermo Fisher Scientific, and other key companies.

Digital therapeutics gaining interest in medical industry: Curebase

15-Feb-2022 By Jenni Spinner

According to a representative from the decentralized trial solutions company, the field of digital therapeutics is poised to gain significant popularity.

Clinical research trends include increased emphasis on study design: Advarra

15-Feb-2022 By Jenni Spinner

An expert from the institutional review board services company advises what trends to look for in the clinical trial industry over the course of coming months.

Evolution of clinical trial data calls for evolved response: ICON

10-Feb-2022 By Jenni Spinner

In the first of a two-part series, leaders from the CRO discuss how study data has progressed in recent years and how trial teams can keep up effectively.

SCOPE 2022

Breast cancer tops list of most studied disease in 2021: Phesi

09-Feb-2022 By Jenni Spinner

The company’s analysis of trials conducted around the world last year shows cancers took four of the top five positions, with COVID-19 in second place.